Mark Morris

CTA Hub Director at Gilead Sciences

Mark Morris is a seasoned professional in the pharmaceutical industry, bringing over 30 years of extensive experience to his role as the Director of the Clinical Trials Application (CTA) Hub at Gilead Sciences. Mark project managed the implementation of EU CTR/CTIS in Gilead which led to the centralisation of clinical trial application activities culminating in the creation of the CTA Hub. He is passionate about process improvement and simplification and has been involved in developing and implementing strategies that streamline operations and enhance collaboration among cross-functional teams. His expertise not only drives productivity but also fosters a culture of continuous improvement.